第53回日本免疫学会学術集会

^○Kaho Oki, Takumi Iwasawa, Kazunori Kato (Dep. of Nutrition. Sci., Grad. Sch. of Health and Sport. Sci., Univ. of Toyo)

^○Ryohei Kondo, Akihiko Nishikimi (Biosafety Administration Division, Research Institute, National Center for Geriatrics and Gerontology)

^○Kosuke Tanegashima¹, Manaka Hasebe^1,2, Risa Saito^1,3, Riku Takahashi^1,3, Takahiko Hara^1,2,3 (1.Stem cell project, Tokyo Metropolitan Institute of Medical Science, 2.Grad. Sch. of Tokyo Metropol. Univ., 3.Grad. Sch. of Tokyo Medical and Dental Univ.)

^○Kairi Murakoshi, Yui Shinzawa, Ka He, So-ichiro Sasaki, Yoshihiro Hayakawa (Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Japan)

^○Ka He¹, Tatsuji Kimura², Kazuyoshi Takeda³, Yoshihiro Hayakawa¹ (1.Institute of Natural Medicine, University of Toyama, 2.Diagnostic Division, Yamasa Corporation, 3.Laboratory of Cell Biology, Graduate School of Medicine, Juntendo University)

^○Kazunori Matsumura, Satoshi Takaki (Department of Immune Regulation, The Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine)

^○Ayami Iijima, Tatsuya Hasegawa (MIRAI Technology Institute, Shiseido Co., Ltd., Yokohama, Japan)

^○Ritsu Nagata^1,3, Yuichi Akama⁴, Pedro Goncalves⁵, Nicolas Serafini⁵, Tomoko Kageyama², Manami Satoh^1,3, Motomu Shimaoka⁴, Hiroshi Ohno^1,3, Naoko Satoh-Takayama^2,3 (1.Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences RIKEN, 2.Precision Immune Regulation RIKEN ECL Research Unit, Center for Integrative Medical Sciences, RIKEN, 3.Graduate School of Medical Life Science, Yokohama City University, 4.Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, 5.Institut Pasteur, Université Paris Cité, Inserm U1223, Innate Immunity Unit)

^○Tetsuro Kobayashi¹, Daisuke Asanuma², Shigeyuki Namiki², Kenzo Hirose², Kazuyo Moro^1,3,4 (1.Laboratory for Innate Immune Systems, RIKEN IMS, 2.Department of Pharmacology, Graduate School of Medicine, The University of Tokyo, 3.Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, 4.Laboratory for Innate Immune Systems, iFReC, Osaka University)

^○Hiromi Matsuyama, Kentaro Machida, Yoichi Dotake, Takahiro Matsuyama, Koichi Takagi, Kentaro Tanaka, Hiromasa lnoue (Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University)

^○Takuya Yashiro¹, Kazuyo Moro^1,2,3 (1.Laboratory for innate immune systems, Graduate school of medicine, Osaka university, 2.Laboratory for Innate Immune Systems, RIKEN-IMS, 3.Laboratory for Innate Immune Systems, IFReC, Osaka University)

^○Emi Irie^1,3, Ichiro Mizushima¹, Ka Kan¹, Yuta Kaieda¹, Junya Tsunoda^1,2, Yohei Mikami¹, Takanori Kanai¹ (1.Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2.Department of Surgery, Keio University School of Medicine, 3.Center for preventive medicine, Keio University)

^○Natsuki Ide^1,2, Kazuki Sato¹, Kenshiro Matsuda^1,3, Kazuko Shibuya^1,3, Akira Shibuya^1,3,4 (1.Department of Immunology, Institute of Medicine, University of Tsukuba, 2.Ph.D. Program in Human Biology, 3.R&D Center for Innovative Drug Discovery, University of Tsukuba, 4.TNAX Biopharma Inc.)

^○Takuma Misawa, Shigeo Koyasu (Laboratory for Immune Cell Systems, RIKEN IMS)

^○Ayana Mori^1,2, Shiho Nagata^1,3, Tomoko Kageyama², Naoko Tachibana³, Hiroshi Ohno^3,4, Naoko Satoh-Takayama^1,2 (1.Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan, 2.Precision Immune Regulation RIKEN ECL research Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 3.Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 4.Laboratory for Immune Regulation, Graduate School of Medicine, Chiba University, Chiba, Japan)

^○Kiwamu Motoyoshi, Takahiro Aoki, Mariko Takami, Shinichiro Motohashi (Department of Medical Immunology, Graduate school of medicine, Chiba University)

^○Hiroki Ishikawa¹, Ryuichi Nagashima^1,2, Yoshihiro Kuno^1,3, Hiraku Sasaki⁴, Chikara Kohda¹, Masayuki Iyoda^1,3 (1.Department of Microbiology and Immunology, Showa University School of Medicine, 2.Division of Immunology, Department of Biosciences, Kitasato University School of Science, 3.Division of Nephrology, Department of Medicine, Showa University School of Medicine, 4.Department of Health Science, Faculty of Health and Sports Science, Juntendo University)

^○Koji Hayashizaki^1,2, Shogo Takatsuka³, Toshio Kanno⁴, Masato Kubo⁵, Yoshimasa Takahashi², Daisuke Kitamura⁶, Yusuke Endo⁴, Yuki Kinjo^1,2 (1.Department of Bacteriology, The Jikei University School of Medicine, 2.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 3.Department of Fungal Infection, National Institute of Infectious Diseases, 4.Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 5.Division of Molecular Pathology, Research Institute for Biomedical Sciences (RIBS), Tokyo University of Science, 6.Division of Cancer Cell Biology, Research Institute for Biomedical Sciences (RIBS), Tokyo University of Science)

^○Chloé Papapetropoulos, Zacarias Garcia, Solenne Marie, Capucine Grandjean, Philippe Bousso, James Di Santo, Nicolas Serafini (Innate Immunity Unit, Institut Pasteur, Inserm U1223)